Recently, Gelatti et al. reported lower prevalence in Brazilian cohort with 43.46% of NSCLC patients with score ≥ 1% of PD-L1 expression and 17.83 ≥ 50% [20]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.